FDA 483 - Opada Alzohaili, M.D. - August 14, 2013
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Opada Alzohaili, M.D. in Dearborn, MI, was cited for significant deficiencies in conducting a clinical investigation. The inspection revealed failures in adhering to the investigational plan, including delays in subject rescue/dose titration, improper investigational product administration and storage, and incomplete safety assessments. Additionally, the firm failed to obtain proper informed consent, maintain accurate case histories, and retain investigational records as required.
ID · a5818699-b9bf-4c9f-a40f-1bba74ff1f97